Global Molecular Residual Disease Detection Supply, Demand and Key Producers, 2023-2029
The global Molecular Residual Disease Detection market size is expected to reach $ 12750 million by 2029, rising at a market growth of 14.9% CAGR during the forecast period (2023-2029).
Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).
This report studies the global Molecular Residual Disease Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Residual Disease Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Residual Disease Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Residual Disease Detection total market, 2018-2029, (USD Million)
Global Molecular Residual Disease Detection total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Residual Disease Detection total market, key domestic companies and share, (USD Million)
Global Molecular Residual Disease Detection revenue by player and market share 2018-2023, (USD Million)
Global Molecular Residual Disease Detection total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Residual Disease Detection total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Molecular Residual Disease Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive, Guardant Health, Invitae, Cergentis B.V, LexentBio, Natera, BGI, Zhiben Medical and Burning Rock Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Residual Disease Detection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Residual Disease Detection Market, By Region:
1. How big is the global Molecular Residual Disease Detection market?
2. What is the demand of the global Molecular Residual Disease Detection market?
3. What is the year over year growth of the global Molecular Residual Disease Detection market?
4. What is the total value of the global Molecular Residual Disease Detection market?
5. Who are the major players in the global Molecular Residual Disease Detection market?
6. What are the growth factors driving the market demand?
Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).
This report studies the global Molecular Residual Disease Detection demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Molecular Residual Disease Detection, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Molecular Residual Disease Detection that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Molecular Residual Disease Detection total market, 2018-2029, (USD Million)
Global Molecular Residual Disease Detection total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Molecular Residual Disease Detection total market, key domestic companies and share, (USD Million)
Global Molecular Residual Disease Detection revenue by player and market share 2018-2023, (USD Million)
Global Molecular Residual Disease Detection total market by Type, CAGR, 2018-2029, (USD Million)
Global Molecular Residual Disease Detection total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Molecular Residual Disease Detection market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Adaptive, Guardant Health, Invitae, Cergentis B.V, LexentBio, Natera, BGI, Zhiben Medical and Burning Rock Medicine, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Molecular Residual Disease Detection market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Molecular Residual Disease Detection Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Tumor-informed Assays
- Tumor-agnostic Assays
- Prognosis
- Adjuvant Treatment Decision-Making
- Surveillance for Postoperative Recurrence
- Other
- Adaptive
- Guardant Health
- Invitae
- Cergentis B.V
- LexentBio
- Natera
- BGI
- Zhiben Medical
- Burning Rock Medicine
- Huidu Medical
- Zhenhe Technology
- ExactSciences
1. How big is the global Molecular Residual Disease Detection market?
2. What is the demand of the global Molecular Residual Disease Detection market?
3. What is the year over year growth of the global Molecular Residual Disease Detection market?
4. What is the total value of the global Molecular Residual Disease Detection market?
5. Who are the major players in the global Molecular Residual Disease Detection market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Molecular Residual Disease Detection Introduction
1.2 World Molecular Residual Disease Detection Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Residual Disease Detection Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Residual Disease Detection Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Residual Disease Detection Market Size (2018-2029)
1.3.3 China Molecular Residual Disease Detection Market Size (2018-2029)
1.3.4 Europe Molecular Residual Disease Detection Market Size (2018-2029)
1.3.5 Japan Molecular Residual Disease Detection Market Size (2018-2029)
1.3.6 South Korea Molecular Residual Disease Detection Market Size (2018-2029)
1.3.7 ASEAN Molecular Residual Disease Detection Market Size (2018-2029)
1.3.8 India Molecular Residual Disease Detection Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Residual Disease Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Residual Disease Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Residual Disease Detection Consumption Value (2018-2029)
2.2 World Molecular Residual Disease Detection Consumption Value by Region
2.2.1 World Molecular Residual Disease Detection Consumption Value by Region (2018-2023)
2.2.2 World Molecular Residual Disease Detection Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Residual Disease Detection Consumption Value (2018-2029)
2.4 China Molecular Residual Disease Detection Consumption Value (2018-2029)
2.5 Europe Molecular Residual Disease Detection Consumption Value (2018-2029)
2.6 Japan Molecular Residual Disease Detection Consumption Value (2018-2029)
2.7 South Korea Molecular Residual Disease Detection Consumption Value (2018-2029)
2.8 ASEAN Molecular Residual Disease Detection Consumption Value (2018-2029)
2.9 India Molecular Residual Disease Detection Consumption Value (2018-2029)
3 WORLD MOLECULAR RESIDUAL DISEASE DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Residual Disease Detection Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Residual Disease Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Residual Disease Detection in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Residual Disease Detection in 2022
3.3 Molecular Residual Disease Detection Company Evaluation Quadrant
3.4 Molecular Residual Disease Detection Market: Overall Company Footprint Analysis
3.4.1 Molecular Residual Disease Detection Market: Region Footprint
3.4.2 Molecular Residual Disease Detection Market: Company Product Type Footprint
3.4.3 Molecular Residual Disease Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Residual Disease Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Residual Disease Detection Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Residual Disease Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Residual Disease Detection Consumption Value Comparison
4.2.1 United States VS China: Molecular Residual Disease Detection Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Residual Disease Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Residual Disease Detection Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Residual Disease Detection Revenue, (2018-2023)
4.4 China Based Companies Molecular Residual Disease Detection Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Residual Disease Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Residual Disease Detection Revenue, (2018-2023)
4.5 Rest of World Based Molecular Residual Disease Detection Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Residual Disease Detection Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Residual Disease Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tumor-informed Assays
5.2.2 Tumor-agnostic Assays
5.3 Market Segment by Type
5.3.1 World Molecular Residual Disease Detection Market Size by Type (2018-2023)
5.3.2 World Molecular Residual Disease Detection Market Size by Type (2024-2029)
5.3.3 World Molecular Residual Disease Detection Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Residual Disease Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Prognosis
6.2.2 Adjuvant Treatment Decision-Making
6.2.3 Surveillance for Postoperative Recurrence
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Molecular Residual Disease Detection Market Size by Application (2018-2023)
6.3.2 World Molecular Residual Disease Detection Market Size by Application (2024-2029)
6.3.3 World Molecular Residual Disease Detection Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Adaptive
7.1.1 Adaptive Details
7.1.2 Adaptive Major Business
7.1.3 Adaptive Molecular Residual Disease Detection Product and Services
7.1.4 Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Adaptive Recent Developments/Updates
7.1.6 Adaptive Competitive Strengths & Weaknesses
7.2 Guardant Health
7.2.1 Guardant Health Details
7.2.2 Guardant Health Major Business
7.2.3 Guardant Health Molecular Residual Disease Detection Product and Services
7.2.4 Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Guardant Health Recent Developments/Updates
7.2.6 Guardant Health Competitive Strengths & Weaknesses
7.3 Invitae
7.3.1 Invitae Details
7.3.2 Invitae Major Business
7.3.3 Invitae Molecular Residual Disease Detection Product and Services
7.3.4 Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Invitae Recent Developments/Updates
7.3.6 Invitae Competitive Strengths & Weaknesses
7.4 Cergentis B.V
7.4.1 Cergentis B.V Details
7.4.2 Cergentis B.V Major Business
7.4.3 Cergentis B.V Molecular Residual Disease Detection Product and Services
7.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Cergentis B.V Recent Developments/Updates
7.4.6 Cergentis B.V Competitive Strengths & Weaknesses
7.5 LexentBio
7.5.1 LexentBio Details
7.5.2 LexentBio Major Business
7.5.3 LexentBio Molecular Residual Disease Detection Product and Services
7.5.4 LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 LexentBio Recent Developments/Updates
7.5.6 LexentBio Competitive Strengths & Weaknesses
7.6 Natera
7.6.1 Natera Details
7.6.2 Natera Major Business
7.6.3 Natera Molecular Residual Disease Detection Product and Services
7.6.4 Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Natera Recent Developments/Updates
7.6.6 Natera Competitive Strengths & Weaknesses
7.7 BGI
7.7.1 BGI Details
7.7.2 BGI Major Business
7.7.3 BGI Molecular Residual Disease Detection Product and Services
7.7.4 BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BGI Recent Developments/Updates
7.7.6 BGI Competitive Strengths & Weaknesses
7.8 Zhiben Medical
7.8.1 Zhiben Medical Details
7.8.2 Zhiben Medical Major Business
7.8.3 Zhiben Medical Molecular Residual Disease Detection Product and Services
7.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Zhiben Medical Recent Developments/Updates
7.8.6 Zhiben Medical Competitive Strengths & Weaknesses
7.9 Burning Rock Medicine
7.9.1 Burning Rock Medicine Details
7.9.2 Burning Rock Medicine Major Business
7.9.3 Burning Rock Medicine Molecular Residual Disease Detection Product and Services
7.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Burning Rock Medicine Recent Developments/Updates
7.9.6 Burning Rock Medicine Competitive Strengths & Weaknesses
7.10 Huidu Medical
7.10.1 Huidu Medical Details
7.10.2 Huidu Medical Major Business
7.10.3 Huidu Medical Molecular Residual Disease Detection Product and Services
7.10.4 Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Huidu Medical Recent Developments/Updates
7.10.6 Huidu Medical Competitive Strengths & Weaknesses
7.11 Zhenhe Technology
7.11.1 Zhenhe Technology Details
7.11.2 Zhenhe Technology Major Business
7.11.3 Zhenhe Technology Molecular Residual Disease Detection Product and Services
7.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Zhenhe Technology Recent Developments/Updates
7.11.6 Zhenhe Technology Competitive Strengths & Weaknesses
7.12 ExactSciences
7.12.1 ExactSciences Details
7.12.2 ExactSciences Major Business
7.12.3 ExactSciences Molecular Residual Disease Detection Product and Services
7.12.4 ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 ExactSciences Recent Developments/Updates
7.12.6 ExactSciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Residual Disease Detection Industry Chain
8.2 Molecular Residual Disease Detection Upstream Analysis
8.3 Molecular Residual Disease Detection Midstream Analysis
8.4 Molecular Residual Disease Detection Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Molecular Residual Disease Detection Introduction
1.2 World Molecular Residual Disease Detection Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Molecular Residual Disease Detection Total Market by Region (by Headquarter Location)
1.3.1 World Molecular Residual Disease Detection Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Molecular Residual Disease Detection Market Size (2018-2029)
1.3.3 China Molecular Residual Disease Detection Market Size (2018-2029)
1.3.4 Europe Molecular Residual Disease Detection Market Size (2018-2029)
1.3.5 Japan Molecular Residual Disease Detection Market Size (2018-2029)
1.3.6 South Korea Molecular Residual Disease Detection Market Size (2018-2029)
1.3.7 ASEAN Molecular Residual Disease Detection Market Size (2018-2029)
1.3.8 India Molecular Residual Disease Detection Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Molecular Residual Disease Detection Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Molecular Residual Disease Detection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Molecular Residual Disease Detection Consumption Value (2018-2029)
2.2 World Molecular Residual Disease Detection Consumption Value by Region
2.2.1 World Molecular Residual Disease Detection Consumption Value by Region (2018-2023)
2.2.2 World Molecular Residual Disease Detection Consumption Value Forecast by Region (2024-2029)
2.3 United States Molecular Residual Disease Detection Consumption Value (2018-2029)
2.4 China Molecular Residual Disease Detection Consumption Value (2018-2029)
2.5 Europe Molecular Residual Disease Detection Consumption Value (2018-2029)
2.6 Japan Molecular Residual Disease Detection Consumption Value (2018-2029)
2.7 South Korea Molecular Residual Disease Detection Consumption Value (2018-2029)
2.8 ASEAN Molecular Residual Disease Detection Consumption Value (2018-2029)
2.9 India Molecular Residual Disease Detection Consumption Value (2018-2029)
3 WORLD MOLECULAR RESIDUAL DISEASE DETECTION COMPANIES COMPETITIVE ANALYSIS
3.1 World Molecular Residual Disease Detection Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Molecular Residual Disease Detection Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Molecular Residual Disease Detection in 2022
3.2.3 Global Concentration Ratios (CR8) for Molecular Residual Disease Detection in 2022
3.3 Molecular Residual Disease Detection Company Evaluation Quadrant
3.4 Molecular Residual Disease Detection Market: Overall Company Footprint Analysis
3.4.1 Molecular Residual Disease Detection Market: Region Footprint
3.4.2 Molecular Residual Disease Detection Market: Company Product Type Footprint
3.4.3 Molecular Residual Disease Detection Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Molecular Residual Disease Detection Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Molecular Residual Disease Detection Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Molecular Residual Disease Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Molecular Residual Disease Detection Consumption Value Comparison
4.2.1 United States VS China: Molecular Residual Disease Detection Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Molecular Residual Disease Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Molecular Residual Disease Detection Companies and Market Share, 2018-2023
4.3.1 United States Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Molecular Residual Disease Detection Revenue, (2018-2023)
4.4 China Based Companies Molecular Residual Disease Detection Revenue and Market Share, 2018-2023
4.4.1 China Based Molecular Residual Disease Detection Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Molecular Residual Disease Detection Revenue, (2018-2023)
4.5 Rest of World Based Molecular Residual Disease Detection Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Molecular Residual Disease Detection Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Molecular Residual Disease Detection Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Tumor-informed Assays
5.2.2 Tumor-agnostic Assays
5.3 Market Segment by Type
5.3.1 World Molecular Residual Disease Detection Market Size by Type (2018-2023)
5.3.2 World Molecular Residual Disease Detection Market Size by Type (2024-2029)
5.3.3 World Molecular Residual Disease Detection Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Molecular Residual Disease Detection Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Prognosis
6.2.2 Adjuvant Treatment Decision-Making
6.2.3 Surveillance for Postoperative Recurrence
6.2.4 Other
6.2.5 Other
6.3 Market Segment by Application
6.3.1 World Molecular Residual Disease Detection Market Size by Application (2018-2023)
6.3.2 World Molecular Residual Disease Detection Market Size by Application (2024-2029)
6.3.3 World Molecular Residual Disease Detection Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Adaptive
7.1.1 Adaptive Details
7.1.2 Adaptive Major Business
7.1.3 Adaptive Molecular Residual Disease Detection Product and Services
7.1.4 Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Adaptive Recent Developments/Updates
7.1.6 Adaptive Competitive Strengths & Weaknesses
7.2 Guardant Health
7.2.1 Guardant Health Details
7.2.2 Guardant Health Major Business
7.2.3 Guardant Health Molecular Residual Disease Detection Product and Services
7.2.4 Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Guardant Health Recent Developments/Updates
7.2.6 Guardant Health Competitive Strengths & Weaknesses
7.3 Invitae
7.3.1 Invitae Details
7.3.2 Invitae Major Business
7.3.3 Invitae Molecular Residual Disease Detection Product and Services
7.3.4 Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Invitae Recent Developments/Updates
7.3.6 Invitae Competitive Strengths & Weaknesses
7.4 Cergentis B.V
7.4.1 Cergentis B.V Details
7.4.2 Cergentis B.V Major Business
7.4.3 Cergentis B.V Molecular Residual Disease Detection Product and Services
7.4.4 Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Cergentis B.V Recent Developments/Updates
7.4.6 Cergentis B.V Competitive Strengths & Weaknesses
7.5 LexentBio
7.5.1 LexentBio Details
7.5.2 LexentBio Major Business
7.5.3 LexentBio Molecular Residual Disease Detection Product and Services
7.5.4 LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 LexentBio Recent Developments/Updates
7.5.6 LexentBio Competitive Strengths & Weaknesses
7.6 Natera
7.6.1 Natera Details
7.6.2 Natera Major Business
7.6.3 Natera Molecular Residual Disease Detection Product and Services
7.6.4 Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Natera Recent Developments/Updates
7.6.6 Natera Competitive Strengths & Weaknesses
7.7 BGI
7.7.1 BGI Details
7.7.2 BGI Major Business
7.7.3 BGI Molecular Residual Disease Detection Product and Services
7.7.4 BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 BGI Recent Developments/Updates
7.7.6 BGI Competitive Strengths & Weaknesses
7.8 Zhiben Medical
7.8.1 Zhiben Medical Details
7.8.2 Zhiben Medical Major Business
7.8.3 Zhiben Medical Molecular Residual Disease Detection Product and Services
7.8.4 Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Zhiben Medical Recent Developments/Updates
7.8.6 Zhiben Medical Competitive Strengths & Weaknesses
7.9 Burning Rock Medicine
7.9.1 Burning Rock Medicine Details
7.9.2 Burning Rock Medicine Major Business
7.9.3 Burning Rock Medicine Molecular Residual Disease Detection Product and Services
7.9.4 Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Burning Rock Medicine Recent Developments/Updates
7.9.6 Burning Rock Medicine Competitive Strengths & Weaknesses
7.10 Huidu Medical
7.10.1 Huidu Medical Details
7.10.2 Huidu Medical Major Business
7.10.3 Huidu Medical Molecular Residual Disease Detection Product and Services
7.10.4 Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Huidu Medical Recent Developments/Updates
7.10.6 Huidu Medical Competitive Strengths & Weaknesses
7.11 Zhenhe Technology
7.11.1 Zhenhe Technology Details
7.11.2 Zhenhe Technology Major Business
7.11.3 Zhenhe Technology Molecular Residual Disease Detection Product and Services
7.11.4 Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Zhenhe Technology Recent Developments/Updates
7.11.6 Zhenhe Technology Competitive Strengths & Weaknesses
7.12 ExactSciences
7.12.1 ExactSciences Details
7.12.2 ExactSciences Major Business
7.12.3 ExactSciences Molecular Residual Disease Detection Product and Services
7.12.4 ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 ExactSciences Recent Developments/Updates
7.12.6 ExactSciences Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Molecular Residual Disease Detection Industry Chain
8.2 Molecular Residual Disease Detection Upstream Analysis
8.3 Molecular Residual Disease Detection Midstream Analysis
8.4 Molecular Residual Disease Detection Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Molecular Residual Disease Detection Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Residual Disease Detection Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Residual Disease Detection Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Residual Disease Detection Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Residual Disease Detection Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Residual Disease Detection Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Residual Disease Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Residual Disease Detection Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Residual Disease Detection Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Residual Disease Detection Players in 2022
Table 12. World Molecular Residual Disease Detection Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Residual Disease Detection Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Residual Disease Detection Player
Table 15. Molecular Residual Disease Detection Market: Company Product Type Footprint
Table 16. Molecular Residual Disease Detection Market: Company Product Application Footprint
Table 17. Molecular Residual Disease Detection Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Residual Disease Detection Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Residual Disease Detection Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Residual Disease Detection Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Residual Disease Detection Revenue Market Share (2018-2023)
Table 23. China Based Molecular Residual Disease Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Residual Disease Detection Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Residual Disease Detection Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Residual Disease Detection Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Residual Disease Detection Revenue Market Share (2018-2023)
Table 29. World Molecular Residual Disease Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Residual Disease Detection Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Residual Disease Detection Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Residual Disease Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Residual Disease Detection Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Residual Disease Detection Market Size by Application (2024-2029) & (USD Million)
Table 35. Adaptive Basic Information, Area Served and Competitors
Table 36. Adaptive Major Business
Table 37. Adaptive Molecular Residual Disease Detection Product and Services
Table 38. Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Adaptive Recent Developments/Updates
Table 40. Adaptive Competitive Strengths & Weaknesses
Table 41. Guardant Health Basic Information, Area Served and Competitors
Table 42. Guardant Health Major Business
Table 43. Guardant Health Molecular Residual Disease Detection Product and Services
Table 44. Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Guardant Health Recent Developments/Updates
Table 46. Guardant Health Competitive Strengths & Weaknesses
Table 47. Invitae Basic Information, Area Served and Competitors
Table 48. Invitae Major Business
Table 49. Invitae Molecular Residual Disease Detection Product and Services
Table 50. Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Invitae Recent Developments/Updates
Table 52. Invitae Competitive Strengths & Weaknesses
Table 53. Cergentis B.V Basic Information, Area Served and Competitors
Table 54. Cergentis B.V Major Business
Table 55. Cergentis B.V Molecular Residual Disease Detection Product and Services
Table 56. Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cergentis B.V Recent Developments/Updates
Table 58. Cergentis B.V Competitive Strengths & Weaknesses
Table 59. LexentBio Basic Information, Area Served and Competitors
Table 60. LexentBio Major Business
Table 61. LexentBio Molecular Residual Disease Detection Product and Services
Table 62. LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. LexentBio Recent Developments/Updates
Table 64. LexentBio Competitive Strengths & Weaknesses
Table 65. Natera Basic Information, Area Served and Competitors
Table 66. Natera Major Business
Table 67. Natera Molecular Residual Disease Detection Product and Services
Table 68. Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Natera Recent Developments/Updates
Table 70. Natera Competitive Strengths & Weaknesses
Table 71. BGI Basic Information, Area Served and Competitors
Table 72. BGI Major Business
Table 73. BGI Molecular Residual Disease Detection Product and Services
Table 74. BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BGI Recent Developments/Updates
Table 76. BGI Competitive Strengths & Weaknesses
Table 77. Zhiben Medical Basic Information, Area Served and Competitors
Table 78. Zhiben Medical Major Business
Table 79. Zhiben Medical Molecular Residual Disease Detection Product and Services
Table 80. Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Zhiben Medical Recent Developments/Updates
Table 82. Zhiben Medical Competitive Strengths & Weaknesses
Table 83. Burning Rock Medicine Basic Information, Area Served and Competitors
Table 84. Burning Rock Medicine Major Business
Table 85. Burning Rock Medicine Molecular Residual Disease Detection Product and Services
Table 86. Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Burning Rock Medicine Recent Developments/Updates
Table 88. Burning Rock Medicine Competitive Strengths & Weaknesses
Table 89. Huidu Medical Basic Information, Area Served and Competitors
Table 90. Huidu Medical Major Business
Table 91. Huidu Medical Molecular Residual Disease Detection Product and Services
Table 92. Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Huidu Medical Recent Developments/Updates
Table 94. Huidu Medical Competitive Strengths & Weaknesses
Table 95. Zhenhe Technology Basic Information, Area Served and Competitors
Table 96. Zhenhe Technology Major Business
Table 97. Zhenhe Technology Molecular Residual Disease Detection Product and Services
Table 98. Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Zhenhe Technology Recent Developments/Updates
Table 100. ExactSciences Basic Information, Area Served and Competitors
Table 101. ExactSciences Major Business
Table 102. ExactSciences Molecular Residual Disease Detection Product and Services
Table 103. ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Molecular Residual Disease Detection Upstream (Raw Materials)
Table 105. Molecular Residual Disease Detection Typical Customers
Table 1. World Molecular Residual Disease Detection Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Molecular Residual Disease Detection Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Molecular Residual Disease Detection Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Molecular Residual Disease Detection Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Molecular Residual Disease Detection Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Molecular Residual Disease Detection Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Molecular Residual Disease Detection Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Molecular Residual Disease Detection Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Molecular Residual Disease Detection Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Molecular Residual Disease Detection Players in 2022
Table 12. World Molecular Residual Disease Detection Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Molecular Residual Disease Detection Company Evaluation Quadrant
Table 14. Head Office of Key Molecular Residual Disease Detection Player
Table 15. Molecular Residual Disease Detection Market: Company Product Type Footprint
Table 16. Molecular Residual Disease Detection Market: Company Product Application Footprint
Table 17. Molecular Residual Disease Detection Mergers & Acquisitions Activity
Table 18. United States VS China Molecular Residual Disease Detection Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Molecular Residual Disease Detection Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
Table 21. United States Based Companies Molecular Residual Disease Detection Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Molecular Residual Disease Detection Revenue Market Share (2018-2023)
Table 23. China Based Molecular Residual Disease Detection Companies, Headquarters (Province, Country)
Table 24. China Based Companies Molecular Residual Disease Detection Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Molecular Residual Disease Detection Revenue Market Share (2018-2023)
Table 26. Rest of World Based Molecular Residual Disease Detection Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Molecular Residual Disease Detection Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Molecular Residual Disease Detection Revenue Market Share (2018-2023)
Table 29. World Molecular Residual Disease Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Molecular Residual Disease Detection Market Size by Type (2018-2023) & (USD Million)
Table 31. World Molecular Residual Disease Detection Market Size by Type (2024-2029) & (USD Million)
Table 32. World Molecular Residual Disease Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Molecular Residual Disease Detection Market Size by Application (2018-2023) & (USD Million)
Table 34. World Molecular Residual Disease Detection Market Size by Application (2024-2029) & (USD Million)
Table 35. Adaptive Basic Information, Area Served and Competitors
Table 36. Adaptive Major Business
Table 37. Adaptive Molecular Residual Disease Detection Product and Services
Table 38. Adaptive Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Adaptive Recent Developments/Updates
Table 40. Adaptive Competitive Strengths & Weaknesses
Table 41. Guardant Health Basic Information, Area Served and Competitors
Table 42. Guardant Health Major Business
Table 43. Guardant Health Molecular Residual Disease Detection Product and Services
Table 44. Guardant Health Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Guardant Health Recent Developments/Updates
Table 46. Guardant Health Competitive Strengths & Weaknesses
Table 47. Invitae Basic Information, Area Served and Competitors
Table 48. Invitae Major Business
Table 49. Invitae Molecular Residual Disease Detection Product and Services
Table 50. Invitae Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Invitae Recent Developments/Updates
Table 52. Invitae Competitive Strengths & Weaknesses
Table 53. Cergentis B.V Basic Information, Area Served and Competitors
Table 54. Cergentis B.V Major Business
Table 55. Cergentis B.V Molecular Residual Disease Detection Product and Services
Table 56. Cergentis B.V Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Cergentis B.V Recent Developments/Updates
Table 58. Cergentis B.V Competitive Strengths & Weaknesses
Table 59. LexentBio Basic Information, Area Served and Competitors
Table 60. LexentBio Major Business
Table 61. LexentBio Molecular Residual Disease Detection Product and Services
Table 62. LexentBio Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. LexentBio Recent Developments/Updates
Table 64. LexentBio Competitive Strengths & Weaknesses
Table 65. Natera Basic Information, Area Served and Competitors
Table 66. Natera Major Business
Table 67. Natera Molecular Residual Disease Detection Product and Services
Table 68. Natera Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Natera Recent Developments/Updates
Table 70. Natera Competitive Strengths & Weaknesses
Table 71. BGI Basic Information, Area Served and Competitors
Table 72. BGI Major Business
Table 73. BGI Molecular Residual Disease Detection Product and Services
Table 74. BGI Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. BGI Recent Developments/Updates
Table 76. BGI Competitive Strengths & Weaknesses
Table 77. Zhiben Medical Basic Information, Area Served and Competitors
Table 78. Zhiben Medical Major Business
Table 79. Zhiben Medical Molecular Residual Disease Detection Product and Services
Table 80. Zhiben Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Zhiben Medical Recent Developments/Updates
Table 82. Zhiben Medical Competitive Strengths & Weaknesses
Table 83. Burning Rock Medicine Basic Information, Area Served and Competitors
Table 84. Burning Rock Medicine Major Business
Table 85. Burning Rock Medicine Molecular Residual Disease Detection Product and Services
Table 86. Burning Rock Medicine Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Burning Rock Medicine Recent Developments/Updates
Table 88. Burning Rock Medicine Competitive Strengths & Weaknesses
Table 89. Huidu Medical Basic Information, Area Served and Competitors
Table 90. Huidu Medical Major Business
Table 91. Huidu Medical Molecular Residual Disease Detection Product and Services
Table 92. Huidu Medical Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Huidu Medical Recent Developments/Updates
Table 94. Huidu Medical Competitive Strengths & Weaknesses
Table 95. Zhenhe Technology Basic Information, Area Served and Competitors
Table 96. Zhenhe Technology Major Business
Table 97. Zhenhe Technology Molecular Residual Disease Detection Product and Services
Table 98. Zhenhe Technology Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Zhenhe Technology Recent Developments/Updates
Table 100. ExactSciences Basic Information, Area Served and Competitors
Table 101. ExactSciences Major Business
Table 102. ExactSciences Molecular Residual Disease Detection Product and Services
Table 103. ExactSciences Molecular Residual Disease Detection Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 104. Global Key Players of Molecular Residual Disease Detection Upstream (Raw Materials)
Table 105. Molecular Residual Disease Detection Typical Customers
LIST OF FIGURES
Figure 1. Molecular Residual Disease Detection Picture
Figure 2. World Molecular Residual Disease Detection Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Residual Disease Detection Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Residual Disease Detection Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Residual Disease Detection Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Residual Disease Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Residual Disease Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Residual Disease Detection by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Residual Disease Detection Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Residual Disease Detection Markets in 2022
Figure 27. United States VS China: Molecular Residual Disease Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Residual Disease Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Residual Disease Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Residual Disease Detection Market Size Market Share by Type in 2022
Figure 31. Tumor-informed Assays
Figure 32. Tumor-agnostic Assays
Figure 33. World Molecular Residual Disease Detection Market Size Market Share by Type (2018-2029)
Figure 34. World Molecular Residual Disease Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Molecular Residual Disease Detection Market Size Market Share by Application in 2022
Figure 36. Prognosis
Figure 37. Adjuvant Treatment Decision-Making
Figure 38. Surveillance for Postoperative Recurrence
Figure 39. Other
Figure 40. Molecular Residual Disease Detection Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
Figure 1. Molecular Residual Disease Detection Picture
Figure 2. World Molecular Residual Disease Detection Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Molecular Residual Disease Detection Total Market Size (2018-2029) & (USD Million)
Figure 4. World Molecular Residual Disease Detection Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Molecular Residual Disease Detection Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Molecular Residual Disease Detection Revenue (2018-2029) & (USD Million)
Figure 13. Molecular Residual Disease Detection Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 16. World Molecular Residual Disease Detection Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 18. China Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 23. India Molecular Residual Disease Detection Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Molecular Residual Disease Detection by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Molecular Residual Disease Detection Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Molecular Residual Disease Detection Markets in 2022
Figure 27. United States VS China: Molecular Residual Disease Detection Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Molecular Residual Disease Detection Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Molecular Residual Disease Detection Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Molecular Residual Disease Detection Market Size Market Share by Type in 2022
Figure 31. Tumor-informed Assays
Figure 32. Tumor-agnostic Assays
Figure 33. World Molecular Residual Disease Detection Market Size Market Share by Type (2018-2029)
Figure 34. World Molecular Residual Disease Detection Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Molecular Residual Disease Detection Market Size Market Share by Application in 2022
Figure 36. Prognosis
Figure 37. Adjuvant Treatment Decision-Making
Figure 38. Surveillance for Postoperative Recurrence
Figure 39. Other
Figure 40. Molecular Residual Disease Detection Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source
